Synthesis and evaluation of a near-infrared fluorescent non-peptidic bivalent integrin alpha(v)beta(3) antagonist for cancer imaging. 2010

Feng Li, and Jiacheng Liu, and Gouri S Jas, and Jiawei Zhang, and Guoting Qin, and Jiong Xing, and Claudia Cotes, and Hong Zhao, and Xukui Wang, and Laura A Diaz, and Zheng-Zheng Shi, and Daniel Y Lee, and King C P Li, and Zheng Li
Department of Radiology, The Methodist Hospital Research Institute, 6565 Fannin Street, B5-022, Houston, Texas 77030, USA.

Computer modeling approaches to identify new inhibitors are essentially a very sophisticated and efficient way to design drugs. In this study, a bivalent nonpeptide intergrin alpha(v)beta(3) antagonist (bivalent IA) has been synthesized on the basis of an in silico rational design approach. A near-infrared (NIR) fluorescent imaging probe has been developed from this bivalent compound. In vitro binding assays have shown that the bivalent IA (IC(50) = 0.40 +/- 0.11 nM) exhibited improved integrin alpha(v)beta(3) affinity in comparison with the monovalent IA (IC(50) = 22.33 +/- 4.51 nM), resulting in an over 50-fold improvement in receptor affinity. NIR imaging probe, bivalent-IA-Cy5.5 conjugate, also demonstrated significantly increased binding affinity (IC(50) = 0.13 +/- 0.02 nM). Fluorescence microscopy studies showed integrin-mediated endocytosis of bivalent-IA-Cy5.5 in U87 cells which was effectively blocked by nonfluorescent bivalent IA. We also demonstrated tumor accumulation of this NIR imaging probe in U87 mouse xenografts.

UI MeSH Term Description Entries
D007259 Infrared Rays That portion of the electromagnetic spectrum usually sensed as heat. Infrared wavelengths are longer than those of visible light, extending into the microwave frequencies. They are used therapeutically as heat, and also to warm food in restaurants. Heat Waves,Heat Wave,Infrared Ray,Ray, Infrared,Rays, Infrared,Wave, Heat,Waves, Heat
D008856 Microscopy, Fluorescence Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. Immunofluorescence microscopy utilizes antibodies that are labeled with fluorescent dye. Fluorescence Microscopy,Immunofluorescence Microscopy,Microscopy, Immunofluorescence,Fluorescence Microscopies,Immunofluorescence Microscopies,Microscopies, Fluorescence,Microscopies, Immunofluorescence
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D005260 Female Females
D005456 Fluorescent Dyes Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. Flourescent Agent,Fluorescent Dye,Fluorescent Probe,Fluorescent Probes,Fluorochrome,Fluorochromes,Fluorogenic Substrates,Fluorescence Agents,Fluorescent Agents,Fluorogenic Substrate,Agents, Fluorescence,Agents, Fluorescent,Dyes, Fluorescent,Probes, Fluorescent,Substrates, Fluorogenic

Related Publications

Feng Li, and Jiacheng Liu, and Gouri S Jas, and Jiawei Zhang, and Guoting Qin, and Jiong Xing, and Claudia Cotes, and Hong Zhao, and Xukui Wang, and Laura A Diaz, and Zheng-Zheng Shi, and Daniel Y Lee, and King C P Li, and Zheng Li
January 2012, Chembiochem : a European journal of chemical biology,
Feng Li, and Jiacheng Liu, and Gouri S Jas, and Jiawei Zhang, and Guoting Qin, and Jiong Xing, and Claudia Cotes, and Hong Zhao, and Xukui Wang, and Laura A Diaz, and Zheng-Zheng Shi, and Daniel Y Lee, and King C P Li, and Zheng Li
January 2006, Molecular imaging and biology,
Feng Li, and Jiacheng Liu, and Gouri S Jas, and Jiawei Zhang, and Guoting Qin, and Jiong Xing, and Claudia Cotes, and Hong Zhao, and Xukui Wang, and Laura A Diaz, and Zheng-Zheng Shi, and Daniel Y Lee, and King C P Li, and Zheng Li
March 2005, Neoplasia (New York, N.Y.),
Feng Li, and Jiacheng Liu, and Gouri S Jas, and Jiawei Zhang, and Guoting Qin, and Jiong Xing, and Claudia Cotes, and Hong Zhao, and Xukui Wang, and Laura A Diaz, and Zheng-Zheng Shi, and Daniel Y Lee, and King C P Li, and Zheng Li
October 2000, Journal of medicinal chemistry,
Feng Li, and Jiacheng Liu, and Gouri S Jas, and Jiawei Zhang, and Guoting Qin, and Jiong Xing, and Claudia Cotes, and Hong Zhao, and Xukui Wang, and Laura A Diaz, and Zheng-Zheng Shi, and Daniel Y Lee, and King C P Li, and Zheng Li
March 2009, Molecular bioSystems,
Feng Li, and Jiacheng Liu, and Gouri S Jas, and Jiawei Zhang, and Guoting Qin, and Jiong Xing, and Claudia Cotes, and Hong Zhao, and Xukui Wang, and Laura A Diaz, and Zheng-Zheng Shi, and Daniel Y Lee, and King C P Li, and Zheng Li
August 2003, Cancer biotherapy & radiopharmaceuticals,
Feng Li, and Jiacheng Liu, and Gouri S Jas, and Jiawei Zhang, and Guoting Qin, and Jiong Xing, and Claudia Cotes, and Hong Zhao, and Xukui Wang, and Laura A Diaz, and Zheng-Zheng Shi, and Daniel Y Lee, and King C P Li, and Zheng Li
September 2004, Bioorganic & medicinal chemistry letters,
Feng Li, and Jiacheng Liu, and Gouri S Jas, and Jiawei Zhang, and Guoting Qin, and Jiong Xing, and Claudia Cotes, and Hong Zhao, and Xukui Wang, and Laura A Diaz, and Zheng-Zheng Shi, and Daniel Y Lee, and King C P Li, and Zheng Li
January 2008, Drug development research,
Feng Li, and Jiacheng Liu, and Gouri S Jas, and Jiawei Zhang, and Guoting Qin, and Jiong Xing, and Claudia Cotes, and Hong Zhao, and Xukui Wang, and Laura A Diaz, and Zheng-Zheng Shi, and Daniel Y Lee, and King C P Li, and Zheng Li
June 2007, Recent patents on anti-cancer drug discovery,
Feng Li, and Jiacheng Liu, and Gouri S Jas, and Jiawei Zhang, and Guoting Qin, and Jiong Xing, and Claudia Cotes, and Hong Zhao, and Xukui Wang, and Laura A Diaz, and Zheng-Zheng Shi, and Daniel Y Lee, and King C P Li, and Zheng Li
December 2007, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!